FDA Warning Wire: Zimmer Biomet Zapped Again
Zimmer Biomet once again found itself in the crosshairs of the U.S. Food and Drug Administration, which also warned two drugmakers in Asia about quality issues such as fiber particles in...To view the full article, register now.
Already a subscriber? Click here to view full article